Related Experiment Videos
Cyclosporine A in atopic dermatitis
1Allergology Department, Institut Universitari Dexeus, Barcelona, Spain.
Allergologia Et Immunopathologia
|September 1, 1993
Summary
Low-dose cyclosporine A offers a potential treatment for severe atopic dermatitis. This oral therapy showed clinical improvement in patients, though side effects were mild and manageable.
Area of Science:
- Dermatology
- Immunology
Background:
- Atopic dermatitis is a chronic, itchy skin condition requiring personalized treatment strategies.
- Severe atopic dermatitis cases may benefit from low-dose oral cyclosporine A, as suggested by recent research.
Observation:
- Two patients with severe atopic dermatitis, high IgE levels, and meeting diagnostic criteria were treated with oral cyclosporine A (5 mg/kg/day).
- Treatment involved monitoring cyclosporine levels, kidney, and liver function, with no contraindications identified.
Findings:
- Clinical improvement was observed within 1-3 weeks, ranging from partial to marked.
- No correlation was found between clinical improvement and reduced serum IgE levels.
- Mild side effects including hypertrichosis, trembling, and gingival hypertrophy were noted.
Implications:
- Cyclosporine A may serve as an effective therapeutic option for severe atopic dermatitis refractory to other treatments.
- Reappearance of symptoms upon discontinuation suggests the need for ongoing management.
- Further investigation into cyclosporine A's efficacy and long-term safety in atopic dermatitis is warranted.